arrow
J

Julie Toubiana

necker-enfants malades hospital
H指数:38
被引数:1.1万

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

Piperacillin Population Pharmacokinetics in Plasma and Peritoneal Fluid and Dosing Optimization in Children Undergoing Liver Transplant: An Optimome Study

哌拉西林在血浆和腹腔液中的群体药代动力学及肝移植儿童给药方案优化:一项Optimome研究

2026-05-290
PRE
Characterization of Streptococcus pyogenes isolates from French children: emm-1 genotype is associated with invasive infections and spread of the M1UK clone
2026-02-020
PRE
Severe Group A Streptococcus Infections in Children During and After the COVID-19 Pandemic: An Interrupted Time-series Analysis in Paris, France, 2018-2023

Flamant, A.; Faury, H.; Luscan, R.; Couloigner, V.; Pouletty, M.; Bustarret, O.; Chappuy, H.; Gaume, M.; Drummond, D.; Pinhas, Y.; et al. 儿童A组链球菌严重感染在COVID-19大流行期间及之后的情况:法国巴黎2018–2023年的中断时间序列分析。Pediatr. Infect. Dis. J. 2025. [Google Scholar] [CrossRef]

2025-10-013
PRE
Success and limitations of the French public health strategy after 2 years of large implementation of Respiratory Syncytial Virus prophylaxis: experience of a tertiary hospital (2018-2025)

法国公共卫生策略在实施呼吸道合胞病毒预防措施2年后的成功与局限性:一家三级医院的经验(2018-2025)

2025-09-170
OAAI
Effectiveness of nirsevimab against hospitalisation for RSV-bronchiolitis during high RSV-B circulation in the second year of nationwide implementation in France: a test-negative case-control study

尼尔瑟维马布在法国全国实施第二年RSV-B高流行期间对RSV细支气管炎住院的有效性:一项排除阴性病例对照研究

2025-09-100
PREAI
Clinical characteristics of cases during the 2024 pertussis epidemic in France, January 2024 to December 2024

2024年法国百日咳疫情期间(2024年1月至12月)病例的临床特征

VACCINE
IF3.5
2025-04-010
OAAI
Nirsevimab and Hospitalization for RSV Bronchiolitis

Nirsevimab和RSV细支气管炎的住院治疗

2024-07-1111
PRE